UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007652 |
|---|---|
| Receipt number | R000008795 |
| Scientific Title | Phase III study of cisplatin plus S-1 (CS) compared with docetaxel and cisplatin plus S-1 (DCS) as first-line therapy for advanced gastric cancer(JCOG1013, GC_CS/DCS_P3 ADOPT) |
| Date of disclosure of the study information | 2012/04/03 |
| Last modified on | 2022/08/30 15:35:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/04/03 13:36:22 | ||
| 2 | Update | 2012/04/03 13:41:48 | Recruitment status |
|
| 3 | Update | 2012/05/25 13:29:00 | Institutions |
|
| 4 | Update | 2012/06/20 11:32:08 | Acronym |
|
| 5 | Update | 2013/12/13 11:55:26 | Key inclusion criteria Key inclusion criteria |
|
| 6 | Update | 2013/12/13 11:57:38 | Division name TEL Organization1 Address1 Email1 Institutions |
|
| 7 | Update | 2013/12/13 12:01:43 | Anticipated trial start date Last follow-up date |
|
| 8 | Update | 2016/03/30 10:58:25 | Recruitment status |
|
| 9 | Update | 2021/01/05 14:18:52 | Recruitment status Date of IRB Date analysis concluded |
|
| 10 | Update | 2022/08/30 15:30:03 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 11 | Update | 2022/08/30 15:35:54 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Category of Funding Organization Organization Organization Address Address Tel |
